Though previous studies have found anti-CD47 and anti-CD117 induced anemia to be mild and fully resolved within 2–3 weeks [30,31], further work will be needed to define the impact of neonatal anti-CD117 and anti-CD47 myeloablation on short and long-term anemia. The gene discussed is CD47; the disease is anemia.